Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Advanced Solid Tumor × olaparib × Clear all

Phase

Status

Recruiting 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Prostatic Neoplasms 7 Breast Neoplasms 6 Ovarian Neoplasms 5 Pancreatic Neoplasms 2 Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombocytosis 1 Solid Tumors 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasm Epithelial 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hodgkin Disease 1 Hereditary Sensory and Autonomic Neuropathies 1 Hematologic Neoplasms 1 Extensive Stage Lung Small Cell Carcinoma 1 Endometrial Neoplasms 1

Interventions

Injections 3 atezolizumab 2 Leucovorin 2 Irinotecan 2 ulixertinib 1 toripalimab 1 tipifarnib 1 pembrolizumab 1 olaparib 1 mirdametinib 1 famitinib 1 camrelizumab 1 Ramucirumab 1 Radiation 1 Paclitaxel 1 IFL protocol 1 Granulocyte Colony-Stimulating Factor 1 Gemcitabine 1 Fluorouracil 1 Docetaxel 1 Bevacizumab 1 BID protein, human 1 Appointments and Schedules 1 Albumin-Bound Paclitaxel 1 APG-1387 1 5-fluorouridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06560632 2026-01-16

POLAR

Repare Therapeutics

Phase 1 Terminated

26 enrolled 14 charts

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡